2020-003698-24: A study to investigate JNJ-40411813 in combination with levetiracetam in epilepsy |
|
|
| Ongoing | 2 | 112 | Europe | JNJ-40411813, JNJ-40411813, Tablet | Janssen-Cilag International NV, Janssen Research and Development LLC, US | Focal Onset Seizures, Seizures, Diseases [C] - Nervous System Diseases [C10] | | | | |
| Completed | 2 | 110 | Europe, US, RoW | JNJ-40411813, Placebo | Janssen Research & Development, LLC, Janssen Research and Development LLC, US | Focal Onset Seizures | 02/24 | 02/24 | | |